Are treatments for vasovagal syncope effective? A meta-analysis

International Journal of Cardiology

Volumn 167, Issue 5, 2013, Pages 1906-1911

  Vyas, Ankur ^a   Swaminathan, Paari Dominic ^a   Zimmerman, Miriam B ^b   Olshansky, Brian ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Alpha adrenergic agonists; Beta adrenergic blockers; Neurocardiogenic syncope; Syncope; Tilt training; Vaso vagal syncope

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ETILEFRINE; MIDODRINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CLINICAL EFFECTIVENESS; CONSERVATIVE TREATMENT; DRUG EFFICACY; EVIDENCE BASED MEDICINE; FAINTNESS; HEART PACING; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; OUTCOME ASSESSMENT; PACEMAKER; PATIENT EDUCATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; SENSING MODE; TILT TRAINING; TREATMENT INDICATION;

ALPHA-ADRENERGIC AGONISTS; BETA-ADRENERGIC BLOCKERS; NEUROCARDIOGENIC SYNCOPE; SYNCOPE; TILT TRAINING; VASO-VAGAL SYNCOPE;

ADRENERGIC AGONISTS; CLINICAL TRIALS AS TOPIC; HUMANS; SEROTONIN UPTAKE INHIBITORS; SYNCOPE, VASOVAGAL; TILT-TABLE TEST; TREATMENT OUTCOME;

EID: 84883286184     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.04.144     Document Type: Article

References (57)

1. E.S. Soteriades, J.C. Evans, and M.G. Larson Incidence and prognosis of syncope N Engl J Med 347 2002 878 885
2. M. Linzer, M. Pontinen, D.T. Gold, G.W. Divine, A. Felder, and W.B. Brooks Impairment of physical and psychosocial function in recurrent syncope J Clin Epidemiol 44 1991 1037 1043
3. M.S. Rose, M.L. Koshman, S. Spreng, and R. Sheldon The relationship between health-related quality of life and frequency of spells in patients with syncope J Clin Epidemiol 53 2000 1209 1216
4. N. van Dijk, M.A. Sprangers, N. Colman, K.R. Boer, W. Wieling, and M. Linzer Clinical factors associated with quality of life in patients with transient loss of consciousness J Cardiovasc Electrophysiol 17 2006 998 1003
5. A. Moya, R. Sutton, and F. Ammirati Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC) Eur Heart J 2009 2631 2671
6. H.C. van Houwelingen, L.R. Arends, and T. Stijnen Advanced methods in meta-analysis: multivariate approach and meta-regression Stat Med 21 2002 589 624
7. F. Ammirati, F. Colivicchi, and M. Santini Effects of intravenous etilefrine in neurocardiogenic syncope induced by head-up tilt testing Am J Cardiol 2000 472 474
8. H. Kaufmann, D. Saadia, and A. Voustianiouk Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study Ann Neurol 2002 342 345
9. A. Moya, G. Permanyer-Miralda, and J. Sagrista-Sauleda Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo J Am Coll Cardiol 1995 65 69
10. A. Perez-Lugones, R. Schweikert, and S. Pavia Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study J Cardiovasc Electrophysiol 2001 935 938
11. Z. Qingyou, D. Junbao, and T. Chaoshu The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope J Pediatr 2006 777 780
12. A. Raviele, M. Brignole, and R. Sutton Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study Circulation 1999 1452 1457
13. C.R. Ward, J.C. Gray, J.J. Gilroy, and R.A. Kenny Midodrine: a role in the management of neurocardiogenic syncope Heart 1998 45 49
14. B.P. Grubb, B. Karas, D. Kosinski, and K. Boehm Preliminary observations on the use of midodrine hydrochloride in the treatment of refractory neurocardiogenic syncope J Interv Card Electrophysiol 3 1999 139 143
15. N. Samniah, S. Sakaguchi, K.G. Lurie, D. Iskos, and D.G. Benditt Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope Am J Cardiol 88 A7 2001 80 83
16. M. Biffi, G. Boriani, and P. Sabbatani Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine Heart 1997 268 272
17. B.A. Eldadah, S.L. Pechnik, C.S. Holmes, J.P. Moak, A.M. Saleem, and D.S. Goldstein Failure of propranolol to prevent tilt-evoked systemic vasodilatation, adrenaline release and neurocardiogenic syncope Clin Sci 2006 209 216
18. P. Flevari, E.G. Livanis, G.N. Theodorakis, E. Zarvalis, T. Mesiskli, and D.T. Kremastinos Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being J Am Coll Cardiol 2002 499 504
19. D.K. Jhamb, B. Singh, and B. Sharda Comparative study of the efficacy of metoprolol and verapamil in patients with syncope and positive head-up tilt test response Am Heart J 1996 608 611
20. J. Kluger, M. Bazunga, R. Goldman, E. O'Rangers, P. Azar, and M.S. Chow Usefulness of intravenous metoprolol to prevent syncope induced by head-up tilt Am J Cardiol 1998 820 823 A10
21. A.H. Madrid, J. Ortega, and J.G. Rebollo Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study J Am Coll Cardiol 2001 554 559
22. N. Mahanonda, K. Bhuripanyo, and C. Kangkagate Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results Am Heart J 1995 1250 1253
23. H. Nakagawa, Y. Kobayashi, and S. Kikushima Long-term effects of pharmacological therapy for vasovagal syncope on the basis of reproducibility during head-up tilt testing Jpn Circ J 1998 727 732
24. R. Sheldon, S. Connolly, and S. Rose Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope Circulation 2006 1164 1170
25. R. Sheldon, S. Rose, P. Flanagan, M.L. Koshman, and S. Killam Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test Am J Cardiol 1996 536 539
26. G.N. Theodorakis, D. Leftheriotis, and E.G. Livanis Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study Europace 2006 193 198
27. R. Ventura, R. Maas, and D. Zeidler A randomized and controlled pilot trial of beta-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test Pacing Clin Electrophysiol 2002 816 821
28. Q. Zhang, H. Jin, L. Wang, J. Chen, C. Tang, and J. Du Randomized comparison of metoprolol versus conventional treatment in preventing recurrence of vasovagal syncope in children and adolescents Med Sci Monit 2008 CR199 203
29. M.M. Cox, B.A. Perlman, and M.R. Mayor Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope J Am Coll Cardiol 26 1995 1293 1298
30. D. Iskos, J. Dutton, M.M. Scheinman, and K.G. Lurie Usefulness of pindolol in neurocardiogenic syncope Am J Cardiol 82 1998 1121 1124 A9.
31. E. Di Girolamo, C. Di Iorio, P. Sabatini, L. Leonzio, C. Barbone, and A. Barsotti Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study J Am Coll Cardiol 1999 1227 1230
32. H. Abe, M. Sumiyoshi, K. Kohshi, and Y. Nakashima Effects of orthostatic self-training on head-up tilt testing for the prevention of tilt-induced neurocardiogenic syncope: comparison of pharmacological therapy Clin Exp Hypertens 2003 191 198
33. E. Di Girolamo, C. Di Iorio, L. Leonzio, P. Sabatini, and A. Barsotti Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: A controlled study Circulation 1999 1798 1801
34. H. Duygu, M. Zoghi, and U. Turk The role of tilt training in preventing recurrent syncope in patients with vasovagal syncope: a prospective and randomized study Pacing Clin Electrophysiol 2008 592 596
35. G. Foglia-Manzillo, F. Giada, and G. Gaggioli Efficacy of tilt training in the treatment of neurally mediated syncope. A randomized study Europace 2004 199 204
36. J. Gajek, D. Zyśko, and W. Mazurek Efficacy of tilt training in patients with vasovagal syncope Kardiol Pol 2006 602 608 discussion 9-10.
37. G. Gardenghi, M.U.P.B. Rondon, and A.M.F.W. Braga The effects of exercise training on arterial baroreflex sensitivity in neurally mediated syncope patients Eur Heart J 2007 2749 2755
38. Y.K. On, J. Park, J. Huh, and J.S. Kim Is home orthostatic self-training effective in preventing neurally mediated syncope? Pacing Clin Electrophysiol 2007 638 643
39. H. Zeng, K. Ge, W. Zhang, G. Wang, and L. Guo The effect of orthostatic training in the prevention of vasovagal syncope and its influencing factors Int Heart J 2008 707 712
40. H. Abe, S. Kondo, K. Kohshi, and Y. Nakashima Usefulness of orthostatic self-training for the prevention of neurocardiogenic syncope Pacing Clin Electrophysiol 25 2002 1454 1458
41. O. Kinay, M. Yazici, and C. Nazli Tilt training for recurrent neurocardiogenic syncope: effectiveness, patient compliance, and scheduling the frequency of training sessions Jpn Heart J 45 2004 833 843
42. T. Reybrouck, H. Heidbuchel, F. Van De Werf, and H. Ector Long-term follow-up results of tilt training therapy in patients with recurrent neurocardiogenic syncope Pacing Clin Electrophysiol 25 2002 1441 1446
43. T. Reybrouck, H. Heidbuchel, F. Van de Werf, and H. Ector Tilt training: a treatment for malignant and recurrent neurocardiogenic syncope Pacing Clin Electrophysiol 23 2000 493 498
44. O. Gurevitz, A. Barsheshet, and D. Bar-Lev Tilt training: does it have a role in preventing vasovagal syncope? Pacing Clin Electrophysiol 30 2007 1499 1505
45. F. Ammirati, F. Colivicchi, M. Santini, and Investigators SDaTS Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial Circulation 2001 52 57
46. F. Ammirati, F. Colivicchi, and S. Toscano DDD pacing with rate drop response function versus DDI with rate hysteresis pacing for cardioinhibitory vasovagal syncope Pacing Clin Electrophysiol 1998 2178 2181
47. S.J. Connolly, R. Sheldon, R.S. Roberts, and M. Gent The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope J Am Coll Cardiol 1999 16 20
48. J.-C. Deharo, A.B. Brunetto, and F. Bellocci DDDR pacing driven by contractility versus DDI pacing in vasovagal syncope: a multicenter, randomized study Pacing Clin Electrophysiol 2003 447 450
49. D. Flammang, M. Antiel, and T. Church Is a pacemaker indicated for vasovagal patients with severe cardioinhibitory reflex as identified by the ATP test? A preliminary randomized trial Europace 1999 140 145
50. K.A. McLeod, N. Wilson, J. Hewitt, J. Norrie, and J.B. Stephenson Cardiac pacing for severe childhood neurally mediated syncope with reflex anoxic seizures Heart 1999 721 725
51. E. Occhetta, M. Bortnik, R. Audoglio, C. Vassanelli, and Investigators IS Closed loop stimulation in prevention of vasovagal syncope. Inotropy Controlled Pacing in Vasovagal Syncope (INVASY): a multicentre randomized, single blind, controlled study Europace 2004 538 547
52. A. Raviele, F. Giada, and C. Menozzi A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE) Eur Heart J 2004 1741 1748
53. R. Sutton, M. Brignole, and C. Menozzi Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators Circulation 2000 294 299
54. D.G. Benditt, R. Sutton, and M.D. Gammage Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. The International Rate-Drop Investigators Group Pacing Clin Electrophysiol 20 1997 832 839
55. D.G. Benditt, R. Sutton, and M. Gammage "Rate-drop response" cardiac pacing for vasovagal syncope. Rate-Drop Response Investigators Group J Interv Card Electrophysiol 3 1999 27 33
56. M.E. Petersen, R. Chamberlain-Webber, A.P. Fitzpatrick, A. Ingram, T. Williams, and R. Sutton Permanent pacing for cardioinhibitory malignant vasovagal syndrome Br Heart J 71 1994 274 281
57. R. Sheldon, M.L. Koshman, W. Wilson, T. Kieser, and S. Rose Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope Am J Cardiol 81 1998 158 162